CAS 41078-02-8

Enprofylline

Description:

Enprofylline is a xanthine derivative that primarily functions as a bronchodilator, making it useful in the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It is characterized by its ability to relax bronchial smooth muscle, thereby improving airflow and alleviating symptoms of bronchospasm. Enprofylline exhibits a moderate affinity for adenosine receptors and inhibits phosphodiesterase, leading to increased levels of cyclic AMP, which contributes to its bronchodilatory effects. The substance is typically administered orally and has a relatively short half-life, necessitating multiple doses throughout the day for sustained therapeutic effect. Enprofylline's pharmacokinetics can be influenced by factors such as age, liver function, and concurrent medications. While it is effective, potential side effects may include gastrointestinal disturbances, headache, and cardiovascular effects, particularly at higher doses. As with any medication, it is essential for patients to consult healthcare professionals for appropriate dosing and monitoring.

Formula: C₈H₁₀N₄O₂

InChI: InChI=1S/C8H10N4O2/c1-2-3-12-6-5(9-4-10-6)7(13)11-8(12)14/h4H,2-3H2,1H3,(H,9,10)(H,11,13,14)

InChI key: InChIKey=SIQPXVQCUCHWDI-UHFFFAOYSA-N

SMILES: C(CC)N1C2=C(C(=O)NC1=O)NC=N2

Synonyms:

• 1H-Purine-2,6-dione, 3,7-dihydro-3-propyl-
• 1H-Purine-2,6-dione, 3,9-dihydro-3-propyl-
• 3,7-Dihydro-3-propyl-1H-purine-2,6-dione
• 3,9-Dihydro-3-Propyl-Purine-2,6-Dione
• 3,9-Dihydro-3-propyl-1H-purine-2,6-dione
• 3-Propyl-1H-purine-2,6(3H,9H)-dione
• 3-Propyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione
• 3-Propyl-2,3,6,9-tetrahydro-1H-purine-2,6-dione
• 3-propyl-3,7-dihydro-1H-purine-2,6-dione
• D 4028
• Enprofilina
• Enprofyllin
• Enprofylline

1H-Purine-2,6-dione, 3,7-dihydro-3-propyl-

CAS: 41078-02-8

Formula: C₈H₁₀N₄O₂

Purity: 95%

Color and Shape: Solid

Molecular weight: 194.1906

Ref: IN-DA00I81G

Enprofylline

CAS: 41078-02-8

Formula: C₈H₁₀N₄O₂

Purity: ≥ 95%

Color and Shape: Off-white to brown powder

Molecular weight: 194.19

Ref: 7W-GP1750

Enprofylline

CAS: 41078-02-8

Enprofylline

Purity: ≥95%

Molecular weight: 194.19g/mol

Ref: 54-BUP09795

Enprofylline

CAS: 41078-02-8

Enprofylline (Enprofilina), a bronchodilator, acts primarily as a competitive nonselective phosphodiesterase inhibitor.

Formula: C₈H₁₀N₄O₂

Purity: 98.37%

Color and Shape: Solid

Molecular weight: 194.19

Ref: TM-T21389

Enprofylline

Controlled Product

CAS: 41078-02-8

Enprofylline is a phosphodiesterase inhibitor that enhances the levels of cyclic AMP, which has been shown to increase locomotor activity and improve cardiac function. It also has been used to treat bowel disease and fat cell accumulation in the liver. Enprofylline has been shown to be effective in treating diabetic neuropathy, as well as polymerase chain reactions for long-term efficacy. This drug is metabolized by adenosine deaminase, leading to an increased level of adenosine in the body. Human serum contains high levels of adenosine deaminase, which can lead to a decrease in enprofylline's effectiveness if administered intravenously or intramuscularly.

Formula: C₈H₁₀N₄O₂

Purity: Min. 95%

Molecular weight: 194.19 g/mol

Ref: 3D-FE38970

Enprofylline

CAS: 41078-02-8

Purity: 98%

Molecular weight: 194.1940002

Ref: 10-F600194

Enprofylline

Controlled Product

CAS: 41078-02-8

Formula: C₈H₁₀N₄O₂

Color and Shape: Neat

Molecular weight: 194.19

Ref: TR-E557680